BALYASNY ASSET MANAGEMENT L.P. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 97 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$7,879,225
+30806.2%
1,010,157
+9845.4%
0.01%
Q2 2023$25,494
-59.0%
10,157
-71.4%
0.00%
Q1 2023$62,23535,5630.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 23,222,222$181,133,3322.32%
Anson Funds Management LP 941,908$7,346,8820.88%
QVT Financial LP 575,705$4,490,4990.42%
Wealth Management Partners, LLC 42,000$327,6000.16%
Pinpoint Asset Management Ltd 120,746$941,8190.13%
VANCE WEALTH, INC. 39,266$306,2750.13%
Sargent Investment Group, LLC 72,000$561,6000.12%
China Universal Asset Management Co., Ltd. 82,473$643,2890.09%
Caption Management, LLC 723,700$5,644,8600.09%
SECTORAL ASSET MANAGEMENT INC 25,000$195,0000.08%
View complete list of SUMMIT THERAPEUTICS INC shareholders